MoneyWorks4Me

Biocon - Quaterly Results

30 Oct 2024 Evaluate
The quarter ended September 2024 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 5254.00 millions.A big loss of -90.78% reported for the quarter ended September 2024 to Rs. 32.00  millions from Rs. 347.00 millions.Operating profit for the quarter ended September 2024 decreased to 1111.00 millions as compared to 1368.00 millions of corresponding quarter ended September 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 5254.00 5187.00 1.29 10360.00 10319.00 0.40 21273.00 19929.00 6.74
Other Income 735.00 696.00 5.60 1154.00 1056.00 9.28 1930.00 2714.00 -28.89
PBIDT 1111.00 1368.00 -18.79 1979.00 2448.00 -19.16 4557.00 2949.00 54.53
Interest 597.00 550.00 8.55 1149.00 1033.00 11.23 1988.00 696.00 185.63
PBDT 514.00 766.00 -32.90 830.00 1560.00 -46.79 2714.00 30881.00 -91.21
Depreciation 305.00 306.00 -0.33 610.00 604.00 0.99 1211.00 1169.00 3.59
PBT 209.00 460.00 -54.57 220.00 956.00 -76.99 1503.00 29712.00 -94.94
TAX 177.00 113.00 56.64 179.00 143.00 25.17 310.00 1228.00 -74.76
Deferred Tax 45.00 31.00 45.16 23.00 22.00 4.55 159.00 -99.00 -260.61
PAT 32.00 347.00 -90.78 41.00 813.00 -94.96 1193.00 28484.00 -95.81
Equity 6003.00 6003.00 0.00 6003.00 6003.00 0.00 6003.00 6003.00 0.00
PBIDTM(%) 21.15 26.37 -19.82 19.10 23.72 -19.48 21.42 14.80 44.76
Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..